OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials
Rosie Bradley, Jeremy Braybrooke, Richard Gray, et al.
The Lancet Oncology (2022) Vol. 23, Iss. 3, pp. 382-392
Open Access | Times Cited: 190
Rosie Bradley, Jeremy Braybrooke, Richard Gray, et al.
The Lancet Oncology (2022) Vol. 23, Iss. 3, pp. 382-392
Open Access | Times Cited: 190
Showing 1-25 of 190 citing articles:
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Sibylle Loibl, Fabrice André, Thomas Bachelot, et al.
Annals of Oncology (2023) Vol. 35, Iss. 2, pp. 159-182
Open Access | Times Cited: 275
Sibylle Loibl, Fabrice André, Thomas Bachelot, et al.
Annals of Oncology (2023) Vol. 35, Iss. 2, pp. 159-182
Open Access | Times Cited: 275
Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality
Amanda Kerr, David Dodwell, Paul McGale, et al.
Cancer Treatment Reviews (2022) Vol. 105, pp. 102375-102375
Open Access | Times Cited: 196
Amanda Kerr, David Dodwell, Paul McGale, et al.
Cancer Treatment Reviews (2022) Vol. 105, pp. 102375-102375
Open Access | Times Cited: 196
Breast cancer: an up‐to‐date review and future perspectives
Ruoxi Hong, Binghe Xu
Cancer Communications (2022) Vol. 42, Iss. 10, pp. 913-936
Open Access | Times Cited: 191
Ruoxi Hong, Binghe Xu
Cancer Communications (2022) Vol. 42, Iss. 10, pp. 913-936
Open Access | Times Cited: 191
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer
Ann H. Partridge, Samuel M. Niman, Monica Ruggeri, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 18, pp. 1645-1656
Open Access | Times Cited: 123
Ann H. Partridge, Samuel M. Niman, Monica Ruggeri, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 18, pp. 1645-1656
Open Access | Times Cited: 123
Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023
Giuseppe Curigliano, Harold J. Burstein, Michael Gnant, et al.
Annals of Oncology (2023) Vol. 34, Iss. 11, pp. 970-986
Open Access | Times Cited: 104
Giuseppe Curigliano, Harold J. Burstein, Michael Gnant, et al.
Annals of Oncology (2023) Vol. 34, Iss. 11, pp. 970-986
Open Access | Times Cited: 104
Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials
Olivia Pagani, Barbara Walley, Gini F. Fleming, et al.
Journal of Clinical Oncology (2022) Vol. 41, Iss. 7, pp. 1376-1382
Open Access | Times Cited: 92
Olivia Pagani, Barbara Walley, Gini F. Fleming, et al.
Journal of Clinical Oncology (2022) Vol. 41, Iss. 7, pp. 1376-1382
Open Access | Times Cited: 92
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022
Nina Ditsch, Achim Wöcke, Michael Untch, et al.
Breast Care (2022) Vol. 17, Iss. 4, pp. 403-420
Open Access | Times Cited: 72
Nina Ditsch, Achim Wöcke, Michael Untch, et al.
Breast Care (2022) Vol. 17, Iss. 4, pp. 403-420
Open Access | Times Cited: 72
What Is Known about Breast Cancer in Young Women?
Jie Wei Zhu, Parsa Charkhchi, Shadia Adekunte, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1917-1917
Open Access | Times Cited: 58
Jie Wei Zhu, Parsa Charkhchi, Shadia Adekunte, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1917-1917
Open Access | Times Cited: 58
Estrogens and the risk of breast cancer: A narrative review of literature
Khayry Al‐Shami, Sajeda Awadi, Almu’atasim Khamees, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e20224-e20224
Open Access | Times Cited: 48
Khayry Al‐Shami, Sajeda Awadi, Almu’atasim Khamees, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e20224-e20224
Open Access | Times Cited: 48
Tamoxifen evolution
Anthony Howell, Sacha J. Howell
British Journal of Cancer (2023) Vol. 128, Iss. 3, pp. 421-425
Open Access | Times Cited: 41
Anthony Howell, Sacha J. Howell
British Journal of Cancer (2023) Vol. 128, Iss. 3, pp. 421-425
Open Access | Times Cited: 41
Patient preferences for CDK4/6 inhibitor treatments in HR+/HER2− early breast cancer: a discrete choice survey study
Erica L. Mayer, Mary Lou Smith, Annie Guérin, et al.
Breast Cancer Research and Treatment (2025)
Open Access | Times Cited: 2
Erica L. Mayer, Mary Lou Smith, Annie Guérin, et al.
Breast Cancer Research and Treatment (2025)
Open Access | Times Cited: 2
The History of Early Breast Cancer Treatment
Judith Ben-Dror, Michal Shalamov, Amir Sonnenblick
Genes (2022) Vol. 13, Iss. 6, pp. 960-960
Open Access | Times Cited: 67
Judith Ben-Dror, Michal Shalamov, Amir Sonnenblick
Genes (2022) Vol. 13, Iss. 6, pp. 960-960
Open Access | Times Cited: 67
Treatment of Breast Cancer in Young Adults
Megan E. Tesch, Ann H. Partridge
American Society of Clinical Oncology Educational Book (2022), Iss. 42, pp. 795-806
Closed Access | Times Cited: 38
Megan E. Tesch, Ann H. Partridge
American Society of Clinical Oncology Educational Book (2022), Iss. 42, pp. 795-806
Closed Access | Times Cited: 38
Opportunities for Achieving the Cancer Moonshot Goal of a 50% Reduction in Cancer Mortality by 2047
Meredith S. Shiels, Stanley Lipkowitz, Nicole G. Campos, et al.
Cancer Discovery (2023) Vol. 13, Iss. 5, pp. 1084-1099
Open Access | Times Cited: 29
Meredith S. Shiels, Stanley Lipkowitz, Nicole G. Campos, et al.
Cancer Discovery (2023) Vol. 13, Iss. 5, pp. 1084-1099
Open Access | Times Cited: 29
Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant ER + breast cancer
Marina Bacci, Nicla Lorito, Alfredo Smiriglia, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 736
Closed Access | Times Cited: 11
Marina Bacci, Nicla Lorito, Alfredo Smiriglia, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 736
Closed Access | Times Cited: 11
Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications
Shiliang Xu, Lingxia Wang, Yuexin Zhao, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 9
Shiliang Xu, Lingxia Wang, Yuexin Zhao, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 9
Mitochondrial metabolism blockade nanoadjuvant reversed immune-resistance microenvironment to sensitize albumin-bound paclitaxel-based chemo-immunotherapy
Zaigang Zhou, Wenjuan Luo, Chunjuan Zheng, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 4087-4101
Open Access | Times Cited: 8
Zaigang Zhou, Wenjuan Luo, Chunjuan Zheng, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 4087-4101
Open Access | Times Cited: 8
Reductions in recurrence in women with early breast cancer entering clinical trials between 1990 and 2009: a pooled analysis of 155 746 women in 151 trials
The Lancet (2024) Vol. 404, Iss. 10461, pp. 1407-1418
Closed Access | Times Cited: 8
The Lancet (2024) Vol. 404, Iss. 10461, pp. 1407-1418
Closed Access | Times Cited: 8
Personalizing Adjuvant Endocrine Therapy for Early-Stage Hormone Receptor–Positive Breast Cancer
Barbara Pistilli, Caroline Lohrisch, Jori Sheade, et al.
American Society of Clinical Oncology Educational Book (2022), Iss. 42, pp. 60-72
Closed Access | Times Cited: 36
Barbara Pistilli, Caroline Lohrisch, Jori Sheade, et al.
American Society of Clinical Oncology Educational Book (2022), Iss. 42, pp. 60-72
Closed Access | Times Cited: 36
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial
Lucia Del Mastro, Francesca Poggio, Eva Blondeaux, et al.
The Lancet Oncology (2022) Vol. 23, Iss. 12, pp. 1571-1582
Closed Access | Times Cited: 34
Lucia Del Mastro, Francesca Poggio, Eva Blondeaux, et al.
The Lancet Oncology (2022) Vol. 23, Iss. 12, pp. 1571-1582
Closed Access | Times Cited: 34
ESR1 fusions and therapeutic resistance in metastatic breast cancer
Zsuzsanna Nagy, Rinath Jeselsohn
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 20
Zsuzsanna Nagy, Rinath Jeselsohn
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 20
Contemporaneous symptom networks and correlates during endocrine therapy among breast cancer patients: A network analysis
Feng Jing, Zheng Zhu, Jiajia Qiu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 20
Feng Jing, Zheng Zhu, Jiajia Qiu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 20
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023
Tjoung‐Won Park‐Simon, Volkmar Müller, Christian Jackisch, et al.
Breast Care (2023) Vol. 18, Iss. 4, pp. 289-305
Open Access | Times Cited: 19
Tjoung‐Won Park‐Simon, Volkmar Müller, Christian Jackisch, et al.
Breast Care (2023) Vol. 18, Iss. 4, pp. 289-305
Open Access | Times Cited: 19
The Future of Breast Cancer Research in the Survivorship Field
Davide Soldato, Luca Arecco, Elisa Agostinetto, et al.
Oncology and Therapy (2023) Vol. 11, Iss. 2, pp. 199-229
Open Access | Times Cited: 18
Davide Soldato, Luca Arecco, Elisa Agostinetto, et al.
Oncology and Therapy (2023) Vol. 11, Iss. 2, pp. 199-229
Open Access | Times Cited: 18
Reporting on invasive lobular breast cancer in clinical trials: a systematic review
Karen Van Baelen, Josephine Van Cauwenberge, Marion Maetens, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Karen Van Baelen, Josephine Van Cauwenberge, Marion Maetens, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7
